Pharmacokinetic, Safety, and Pharmacodynamic Properties of Teverelix Trifluoroacetate, a Novel Gonadotropin‐Releasing Hormone Antagonist, in Healthy Adult Subjects-Reference-Cited by-同舟云学术

Pharmacokinetic, Safety, and Pharmacodynamic Properties of Teverelix Trifluoroacetate, a Novel Gonadotropin‐Releasing Hormone Antagonist, in Healthy Adult Subjects

Published:2021-08-26 Issue:2 Volume:11 Page:257-269
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharm in Drug Dev

Author:

MacLean Carol M.¹,Godsafe Zona¹,Soto‐Forte Pablo²,Larsen Finn¹

Affiliation:

1. Antev Ltd London UK

2. PAREXEL Early Phase Clinical Unit Northwick Park Hospital Harrow UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.1008

Reference24 articles.

1. Subcutaneous Injection Volume of Biopharmaceuticals—Pushing the Boundaries

2. Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration

3. Hormone Treatment of Endometriosis

4. Cardiovascular morbidity in a randomized trial comparing GnRH-agonist and antagonist among patients with advanced prostate cancer.

5. Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long acting injectables for the treatment of prostate cancer;Journal of Drug Delivery Science and Technology;2024-10

2. Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update;Expert Opinion on Emerging Drugs;2024-06-14

3. A Model‐Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular Risk;Clinical Pharmacology in Drug Development;2024-05-17

4. Myrrh Attenuates Gonadal Toxicity and DNA Fragmentation Induced by Ethanol in Male Rats;Indian Journal of Animal Research;2023-10-10

5. Targeting P21-Activated Kinase-1 for Metastatic Prostate Cancer;Cancers;2023-04-11